Medical Developments International Limited (ASX:MVP)
Australia
· Delayed Price · Currency is AUD 0.6400
+0.0700 (12.28%)
May 2, 2025, 4:10 PM AEST
ASX:MVP Income Statement
Financials in millions AUD. Fiscal year is July - June.
Millions AUD. Fiscal year is Jul - Jun.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | Jun '20 Jun 30, 2020 | 2015 - 2019 |
| Revenue | 38.05 | 33.15 | 32.34 | 21.94 | 25.27 | 22.54 | Upgrade
|
| Revenue Growth (YoY) | 13.44% | 2.51% | 47.37% | -13.17% | 12.15% | 7.95% | Upgrade
|
| Cost of Revenue | 9.97 | 8.78 | 10.13 | 6.74 | 4.77 | 7.54 | Upgrade
|
| Gross Profit | 28.08 | 24.37 | 22.21 | 15.21 | 20.51 | 14.99 | Upgrade
|
| Selling, General & Admin | 26.15 | 35.37 | 36.4 | 24.81 | 20.23 | 10.97 | Upgrade
|
| Other Operating Expenses | - | - | - | - | - | 1.58 | Upgrade
|
| Operating Expenses | 29.62 | 38.76 | 39.52 | 27.75 | 23.98 | 12.55 | Upgrade
|
| Operating Income | -1.54 | -14.4 | -17.3 | -12.55 | -3.47 | 2.44 | Upgrade
|
| Interest Expense | -0.08 | -0.09 | -0.1 | -0.1 | -0.12 | -0.12 | Upgrade
|
| Interest & Investment Income | 0.32 | 0.4 | 0.66 | 0.47 | 0.07 | 0.34 | Upgrade
|
| Other Non Operating Income (Expenses) | -2.15 | -2.47 | -2.97 | -3.15 | -2.5 | -2.34 | Upgrade
|
| EBT Excluding Unusual Items | -3.45 | -16.55 | -19.71 | -15.33 | -6.02 | 0.32 | Upgrade
|
| Merger & Restructuring Charges | -15.8 | -15.8 | -6.71 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | -0.58 | -4.71 | - | Upgrade
|
| Asset Writedown | -0.57 | -0.57 | - | - | -4.25 | - | Upgrade
|
| Other Unusual Items | - | - | 18.93 | - | - | - | Upgrade
|
| Pretax Income | -19.83 | -32.93 | -7.49 | -15.91 | -14.98 | 0.32 | Upgrade
|
| Income Tax Expense | 9.92 | 8.07 | -1.88 | -3.5 | -2.41 | -0.06 | Upgrade
|
| Net Income | -29.74 | -40.99 | -5.61 | -12.41 | -12.57 | 0.38 | Upgrade
|
| Net Income to Common | -29.74 | -40.99 | -5.61 | -12.41 | -12.57 | 0.38 | Upgrade
|
| Net Income Growth | - | - | - | - | - | -63.49% | Upgrade
|
| Shares Outstanding (Basic) | 97 | 86 | 84 | 71 | 68 | 66 | Upgrade
|
| Shares Outstanding (Diluted) | 97 | 86 | 84 | 71 | 68 | 66 | Upgrade
|
| Shares Change (YoY) | 12.22% | 2.41% | 18.23% | 4.11% | 3.88% | 1.46% | Upgrade
|
| EPS (Basic) | -0.31 | -0.47 | -0.07 | -0.17 | -0.18 | 0.01 | Upgrade
|
| EPS (Diluted) | -0.31 | -0.47 | -0.07 | -0.17 | -0.18 | 0.01 | Upgrade
|
| EPS Growth | - | - | - | - | - | -63.89% | Upgrade
|
| Free Cash Flow | -5.35 | -11.57 | -18.28 | -11.98 | -10.14 | -1.32 | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.13 | -0.22 | -0.17 | -0.15 | -0.02 | Upgrade
|
| Dividend Per Share | - | - | - | - | - | 0.020 | Upgrade
|
| Dividend Growth | - | - | - | - | - | -50.00% | Upgrade
|
| Gross Margin | 73.80% | 73.50% | 68.69% | 69.31% | 81.14% | 66.53% | Upgrade
|
| Operating Margin | -4.03% | -43.43% | -53.51% | -57.17% | -13.75% | 10.83% | Upgrade
|
| Profit Margin | -78.16% | -123.66% | -17.34% | -56.54% | -49.72% | 1.68% | Upgrade
|
| Free Cash Flow Margin | -14.05% | -34.91% | -56.53% | -54.58% | -40.11% | -5.86% | Upgrade
|
| EBITDA | 0.23 | -12.71 | -15.89 | -11.35 | -1.95 | 3.7 | Upgrade
|
| EBITDA Margin | 0.59% | -38.33% | -49.14% | -51.72% | -7.70% | 16.41% | Upgrade
|
| D&A For EBITDA | 1.76 | 1.69 | 1.41 | 1.2 | 1.53 | 1.26 | Upgrade
|
| EBIT | -1.54 | -14.4 | -17.3 | -12.55 | -3.47 | 2.44 | Upgrade
|
| EBIT Margin | -4.03% | -43.43% | -53.51% | -57.17% | -13.75% | 10.83% | Upgrade
|
| Revenue as Reported | - | - | - | - | - | 22.54 | Upgrade
|
Updated Feb 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.